Translational Medicine Communications (Aug 2021)
Correction to: Mesenchymal stem cells in the treatment of severe COVID-19
- Santosh Kesari,
- Gregory C. Kasper,
- Lev Verkh,
- Terese C. Hammond,
- Marla L. Matal,
- Jay W. Hammerling,
- Nikolai Tankovich,
- Adrianus P. Lim,
- Kevin H. Zhao,
- Tiffany Juarez,
- Roberta E. Redfern,
- Jaya M. Gill,
- Natsuko Nomura,
- Audrey Hiemer,
- Annie Heng,
- Jessica Shoemaker
Affiliations
- Santosh Kesari
- Pacific Neuroscience Institute and Providence Saint John’s Health Center
- Gregory C. Kasper
- ProMedica Toledo Hospital
- Lev Verkh
- Stemedica Cell Technologies, Inc.
- Terese C. Hammond
- Providence Saint John’s Health Center
- Marla L. Matal
- ProMedica Toledo Hospital
- Jay W. Hammerling
- ProMedica Toledo Hospital
- Nikolai Tankovich
- Stemedica Cell Technologies, Inc.
- Adrianus P. Lim
- ProMedica Toledo Hospital
- Kevin H. Zhao
- ProMedica Toledo Hospital
- Tiffany Juarez
- Pacific Neuroscience Institute and Providence Saint John’s Health Center
- Roberta E. Redfern
- ProMedica Toledo Hospital
- Jaya M. Gill
- Pacific Neuroscience Institute
- Natsuko Nomura
- Pacific Neuroscience Institute and Providence Saint John’s Health Center
- Audrey Hiemer
- Pacific Neuroscience Institute and Providence Saint John’s Health Center
- Annie Heng
- Pacific Neuroscience Institute and Providence Saint John’s Health Center
- Jessica Shoemaker
- ProMedica Toledo Hospital
- DOI
- https://doi.org/10.1186/s41231-021-00098-x
- Journal volume & issue
-
Vol. 6,
no. 1
pp. 1 – 1
Abstract
No abstracts available.
